These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 10515349)

  • 1. Neutropenic proctosigmoiditis complicating breast cancer chemotherapy.
    Sweeney T; Rieger N; Mackay J
    Aust N Z J Surg; 1999 Sep; 69(9):681-2. PubMed ID: 10515349
    [No Abstract]   [Full Text] [Related]  

  • 2. Adjuvant docetaxel for node-positive breast cancer.
    Ahluwalia MS; Daw HA
    N Engl J Med; 2005 Sep; 353(9):954-5; author reply 954-5. PubMed ID: 16135845
    [No Abstract]   [Full Text] [Related]  

  • 3. Adjuvant docetaxel for node-positive breast cancer.
    Noronha V
    N Engl J Med; 2005 Sep; 353(9):954-5; author reply 954-5. PubMed ID: 16136712
    [No Abstract]   [Full Text] [Related]  

  • 4. Adjuvant chemotherapy in breast cancer: back to the future.
    Colleoni M; Goldhirsch A
    Onkologie; 2003 Apr; 26(2):111-2. PubMed ID: 12771517
    [No Abstract]   [Full Text] [Related]  

  • 5. Randomized double-blind prospective trial to evaluate the effects of sargramostim versus placebo in a moderate-dose fluorouracil, doxorubicin, and cyclophosphamide adjuvant chemotherapy program for stage II and III breast cancer.
    Jones SE; Schottstaedt MW; Duncan LA; Kirby RL; Good RH; Mennel RG; George TK; Snyder DA; Watkins DL; Denham CA; Hoyes FA; Rubin AS
    J Clin Oncol; 1996 Nov; 14(11):2976-83. PubMed ID: 8918495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase I trial of recombinant human granulocyte-macrophage colony-stimulating factor derived from yeast in patients with breast cancer receiving cyclophosphamide, doxorubicin, and fluorouracil.
    O'Reilly SE; Gelmon KA; Onetto N; Parente J; Rubinger M; Page RA; Plenderleith IH
    J Clin Oncol; 1993 Dec; 11(12):2411-6. PubMed ID: 8246030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pseudomembranous colitis complicating chemotherapy.
    Iveson TJ; Chan A
    Lancet; 1992 Jan; 339(8786):192-3. PubMed ID: 1346058
    [No Abstract]   [Full Text] [Related]  

  • 8. Randomized, double-blind, placebo-controlled trial to evaluate the hematopoietic growth factor PIXY321 after moderate-dose fluorouracil, doxorubicin, and cyclophosphamide in stage II and III breast cancer.
    Jones SE; Khandelwal P; McIntyre K; Mennel R; Orr D; Kirby R; Agura E; Duncan L; Hyman W; Roque T; Regan D; Schuster M; Dimitrov N; Garrison L; Lange M
    J Clin Oncol; 1999 Oct; 17(10):3025-32. PubMed ID: 10506596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Enterocolitis in a neutropenic patient and bacteremia caused by Clostridium septicum].
    Sánchez R; Garduño E; Asencio MA; Blanco J
    Enferm Infecc Microbiol Clin; 1998 Oct; 16(8):387. PubMed ID: 9835162
    [No Abstract]   [Full Text] [Related]  

  • 10. Neoadjuvant pegylated liposomal doxorubicin in combination with cisplatin and infusional fluoruracil (CCF) with and without endocrine therapy in locally advanced primary or recurrent breast cancer.
    Torrisi R; Montagna E; Scarano E; Dellapasqua S; Cancello G; Iorfida M; Luini A; Veronesi P; Viale G; Goldhirsch A; Colleoni M
    Breast; 2011 Feb; 20(1):34-8. PubMed ID: 20638282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adjuvant chemotherapy with TAC (docetaxel, doxorubicin, and cyclophosphamide) in patients with breast cancer--incidence of neutropenic fever outside clinical trials.
    Passos-Coelho JL; Esteves S; Vieira PA; Isidoro M; Ribeiro M; Oliveira J; Moreira AR
    Breast J; 2011; 17(5):539-41. PubMed ID: 21899649
    [No Abstract]   [Full Text] [Related]  

  • 12. Relationship between ABCB1 gene polymorphisms and severe neutropenia in patients with breast cancer treated with doxorubicin/cyclophosphamide chemotherapy.
    Ikeda M; Tsuji D; Yamamoto K; Kim YI; Daimon T; Iwabe Y; Hatori M; Makuta R; Hayashi H; Inoue K; Nakamichi H; Shiokawa M; Itoh K
    Drug Metab Pharmacokinet; 2015 Apr; 30(2):149-53. PubMed ID: 25989890
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Role of G-CSF for breast cancer chemotherapy].
    Suzuki Y; Saito Y; Tokuda Y
    Nihon Rinsho; 2007 Jun; 65 Suppl 6():572-4. PubMed ID: 17679213
    [No Abstract]   [Full Text] [Related]  

  • 14. Phase I studies of fluorouracil, doxorubicin and vinorelbine without (FAN) and with (SUPERFAN) folinic acid in patients with advanced breast cancer.
    Goss PE; Fine S; Gelmon K; Rudinskas L; Ottaway J; Myles J; James K; Paul K; Rodgers A; Pritchard KI
    Cancer Chemother Pharmacol; 1997; 41(1):53-60. PubMed ID: 9443614
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth factor allows effective dose-intensive regimen in advanced breast cancer patients.
    Oncology (Williston Park); 1995 Jul; 9(7):684. PubMed ID: 8924381
    [No Abstract]   [Full Text] [Related]  

  • 16. High-dose, brief duration, multiagent chemotherapy for metastatic breast cancer.
    Lamar RE; Greco FA; Johnson DH; Murphy PB; Hainsworth JD
    Cancer; 1994 Apr; 73(7):1842-8. PubMed ID: 8137208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Muehrcke's lines on nails after cyclophosphamide/adriamycin/fluorouracil.
    Gül U; Kiliç A
    Ann Pharmacother; 2004 Jun; 38(6):1089-90. PubMed ID: 15122002
    [No Abstract]   [Full Text] [Related]  

  • 18. Toxicity of etoposide, doxorubicin, and cisplatin in gastric cancer.
    Sparano JA; Wiernik PH
    J Clin Oncol; 1990 May; 8(5):938-9. PubMed ID: 2332775
    [No Abstract]   [Full Text] [Related]  

  • 19. Citrobacter freundii and fatal neutropenic enterocolitis following adjuvant chemotherapy for breast cancer.
    Clemons MJ; Valle JW; Harris M; Ellenbogen S; Howell A
    Clin Oncol (R Coll Radiol); 1997; 9(3):172-5. PubMed ID: 9269550
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toxicity of dual HER2-blockade with pertuzumab added to anthracycline versus non-anthracycline containing chemotherapy as neoadjuvant treatment in HER2-positive breast cancer: The TRAIN-2 study.
    van Ramshorst MS; van Werkhoven E; Honkoop AH; Dezentjé VO; Oving IM; Mandjes IA; Kemper I; Smorenburg CH; Stouthard JM; Linn SC; Sonke GS;
    Breast; 2016 Oct; 29():153-9. PubMed ID: 27498129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.